Florian Holsboer

	Florian Holsboer, Prof. Dr. med. Dr. rer. nat. Dr. h.c. Director of the Max Planck Institute of Psychiatry Management
	Phone:	089/30622-220
	Fax:	089/30622-483
	Email:	holsboer[a]mpipsykl.mpg.de
	Interests:	Affective disorders, depression, anxiety, central regulation of stress hormones, sleep physiology, molecular and clinical psychopharmacology, pharmacogenetics, personalised medicine

CV: Born in Munich. Study of chemistry and medicine at the University of Munich. Residency at the Department of Psychiatry, University of Munich and at the Department of Psychiatry, University of Mainz. 1984 postdoctoral lecturing qualification in psychiatry. 1987-1989 Professor of Psychiatry at the University of Freiburg. Since 1989 Director of the Max Planck Institute of Psychiatry, Munich. Honorary Professor at the Medical Faculty of the Ludwig Maximilians University of Munich since 1990. CV (pdf) Homepage of Prof. Florian Holsboer
Selected publications: Filiou, M., Zhang, Y., Teplytska, L., Reckow, S., Gormanns, P., Maccarrone, G., Frank, E., Keßler, M., Hambsch, B., Nußbaumer, M., Bunck, M., Ludwig, T., Yassouridis, A., Holsboer, F., Landgraf, R., Turck, C.: Proteomics and metabolomics analyses of a trait anxiety mouse model reveals divergent mitochondrial pathways. Biological Psychiatry, July 2011, Epub ahead of print Mehta, D., Gonik, M., Klengel, T., Rex-Haffner, M., Menke, A., Rubel, J., Mercer, K., Pütz, B., Bradley, B., Holsboer, F., Ressler, K., Müller-Myhsok, B.,Binder, EB (2011) Using polymorphisms in FKBP5 to define biologically distinct subtypes of posttraumatic stress disorder: evidence from endocrine and gene expression studies. Archives of General Psychiatry 68: 901-910 Refojo, D., Schweizer, M., Kuehne, C., Ehrenberg, S., Thoeringer, C., Vogl, A., Dedic, N., Schumacher, M., von Wolff, G., Avrabos, C., Touma, C., Engblom, D., Schütz, G., Nave, K., Eder, M., Wotjak, C., Sillaber, I., Holsboer, F., Wurst, W., Deussing, J. (2011) Glutamatergic and dopaminergic neurons mediate anxiogenic and anxiolytic effects of CRHR1. Science 333:1903-1907 Kohli, M., Lucae, S., Sämann, P., Schmidt, M., Demirkan, A., Hek, K., Roeske, D., Alexander, M., Salyakina, D., Ripke, S., Höhn, D., Specht, M., Menke, A., Hennings, J., Heck, A., Wolf, C., Ising, M., Schreiber, Czisch, M., Müller, M., Uhr, M., Bettecken, T., Becker, A, Schramm, J., Rietschel, M., Maier, W., Bradley, B., Ressler, K., Nöthen, M., Cichon, S., Craig, I., Breen, G., Lewis, C., Hofman, A., Tiemeier, H., van Duijn, C., Holsboer, F., Müller-Myhsok, B., Binder, E. (2011) The neuronal transporter gene SLC6A15 confers risk to major depression. Neuron 70: 252-265 Uhr M, Tontsch A, Namendorf C, Ripke S, Lucae S, Ising M, Dose T, Ebinger M, Rosenhagen M, Kohli M, Kloiber S, Salyakina D, Bettecken T, Specht M, Pütz B, Binder EB, Müller-Myhsok B, Holsboer F. (2008) Polymorphisms in the drug-transporter gene ABCB1 predict antidepressant treatment response in depression. Neuron 57: 203-209 Holsboer F (2008) How can we realize the promise of personalized antidepressant medicines? Nat Rev Neurosci. 2008 Aug;9(8):638-46

Florian Holsboer

Florian Holsboer, Prof. Dr. med. Dr. rer. nat. Dr. h.c.